Showing 18,201 - 18,220 results of 78,729 for search '(( a e decrease ) OR ( 50 ((((ms decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.53s Refine Results
  1. 18201

    Table_1_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  2. 18202

    Table_5_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  3. 18203

    Table_3_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  4. 18204

    Table_2_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.DOCX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  5. 18205

    Table_4_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  6. 18206
  7. 18207
  8. 18208

    Protein identification list. by Yang Zhang (30734)

    Published 2024
    “…After MEL treatment, the expression of collagen III and α-SMA decreased, the expression of E-cadherin increased, and the expression of vimentin and N-cadherin also decreased. …”
  9. 18209
  10. 18210

    Euphorbia kansui reactivates HIV in a model of HIV latency using resting human CD4+ T cells. by Daniele C. Cary (3559394)

    Published 2016
    “…Cells were infected with VSV-G-pseudotyped HIV-1 NL4.3 HSA R+E- for 24 hours. Infectious virus was removed and cells were maintained over 12 days with decreasing concentrations of IL-2 to establish latency. …”
  11. 18211
  12. 18212

    Growth and B12 uptake of <i>C. reinhardtii</i> metE7 in axenic cultures containing <i>7.5×10<sup>−14</sup> mol</i>/<i>mL</i> B12 (i.e. <i>100 ng</i>/<i>L</i>). by Hannah Laeverenz Schlogelhofer (10834313)

    Published 2021
    “…<p>(A) Growth of <i>C</i>. <i>reinhardtii</i> metE7 in Tris minimal medium + 7.5×10<sup>−14</sup> <i>mol</i>/<i>mL</i> B<sub>12</sub> measured by counting cell density using a Z2 particle count analyser (Beckman Coulter Ltd). …”
  13. 18213
  14. 18214
  15. 18215
  16. 18216
  17. 18217
  18. 18218
  19. 18219

    Table_1_Family psychoeducation to improve outcome in caregivers and patients with schizophrenia: a randomized clinical trial.docx by Arnaud Tessier (1734355)

    Published 2023
    “…</p>Results<p>On the 25 patients included, the mean age was 33.3 years (SD = 9.7) with a mean duration of disease of 7.48 years (SD = 7.1). …”
  20. 18220